625 related articles for article (PubMed ID: 9270030)
1. Inhibitors of both nuclear factor-kappaB and activator protein-1 activation block the neoplastic transformation response.
Li JJ; Westergaard C; Ghosh P; Colburn NH
Cancer Res; 1997 Aug; 57(16):3569-76. PubMed ID: 9270030
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of tumor promoter-induced transformation by retinoids that transrepress AP-1 without transactivating retinoic acid response element.
Li JJ; Dong Z; Dawson MI; Colburn NH
Cancer Res; 1996 Feb; 56(3):483-9. PubMed ID: 8564958
[TBL] [Abstract][Full Text] [Related]
3. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
[TBL] [Abstract][Full Text] [Related]
4. ET-18-OCH3 inhibits nuclear factor-kappa B activation by 12-O-tetradecanoylphorbol-13-acetate but not by tumor necrosis factor-alpha or interleukin 1 alpha.
Daniel LW; Civoli F; Rogers MA; Smitherman PK; Raju PA; Roederer M
Cancer Res; 1995 Nov; 55(21):4844-9. PubMed ID: 7585518
[TBL] [Abstract][Full Text] [Related]
5. Honokiol inhibits TNF-alpha-stimulated NF-kappaB activation and NF-kappaB-regulated gene expression through suppression of IKK activation.
Tse AK; Wan CK; Shen XL; Yang M; Fong WF
Biochem Pharmacol; 2005 Nov; 70(10):1443-57. PubMed ID: 16181613
[TBL] [Abstract][Full Text] [Related]
6. Tumor promoter-induced ornithine decarboxylase gene expression occurs independently of AP-1 activation.
Jansen AP; Colburn NH; Verma AK
Oncogene; 1999 Oct; 18(42):5806-13. PubMed ID: 10523861
[TBL] [Abstract][Full Text] [Related]
7. Expression of dominant negative Erk2 inhibits AP-1 transactivation and neoplastic transformation.
Watts RG; Huang C; Young MR; Li JJ; Dong Z; Pennie WD; Colburn NH
Oncogene; 1998 Dec; 17(26):3493-8. PubMed ID: 10030673
[TBL] [Abstract][Full Text] [Related]
8. Regulation of NF-kappaB and HIV-1 LTR activity in mouse L cells by ultraviolet radiation: LTR trans-activation in a nonirradiated genome in heterokaryons.
Miller SC; Taylor A; Watanabe K; Mok K; Torti FM
Exp Cell Res; 1997 Jan; 230(1):9-21. PubMed ID: 9013701
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect on activator protein-1, nuclear factor-kappaB, and cell transformation by extracts of strawberries (Fragaria x ananassa Duch.).
Wang SY; Feng R; Lu Y; Bowman L; Ding M
J Agric Food Chem; 2005 May; 53(10):4187-93. PubMed ID: 15884858
[TBL] [Abstract][Full Text] [Related]
10. A novel transformation suppressor, Pdcd4, inhibits AP-1 transactivation but not NF-kappaB or ODC transactivation.
Yang HS; Jansen AP; Nair R; Shibahara K; Verma AK; Cmarik JL; Colburn NH
Oncogene; 2001 Feb; 20(6):669-76. PubMed ID: 11314000
[TBL] [Abstract][Full Text] [Related]
11. Arsenite enhances tumor necrosis factor-alpha-induced expression of vascular cell adhesion molecule-1.
Tsou TC; Yeh SC; Tsai EM; Tsai FY; Chao HR; Chang LW
Toxicol Appl Pharmacol; 2005 Nov; 209(1):10-8. PubMed ID: 16271621
[TBL] [Abstract][Full Text] [Related]
12. Retinyl methyl ether down-regulates activator protein 1 transcriptional activation in breast cancer cells.
Agadir A; Shealy YF; Hill DL; Zhang X
Cancer Res; 1997 Aug; 57(16):3444-50. PubMed ID: 9270011
[TBL] [Abstract][Full Text] [Related]
13. Transformation nonresponsive cells owe their resistance to lack of p65/nuclear factor-kappaB activation.
Hsu TC; Nair R; Tulsian P; Camalier CE; Hegamyer GA; Young MR; Colburn NH
Cancer Res; 2001 May; 61(10):4160-8. PubMed ID: 11358840
[TBL] [Abstract][Full Text] [Related]
14. ERK1/2 mediates TNF-alpha-induced matrix metalloproteinase-9 expression in human vascular smooth muscle cells via the regulation of NF-kappaB and AP-1: Involvement of the ras dependent pathway.
Moon SK; Cha BY; Kim CH
J Cell Physiol; 2004 Mar; 198(3):417-27. PubMed ID: 14755547
[TBL] [Abstract][Full Text] [Related]
15. Mutant human tumor suppressor p53 modulates the activation of mitogen-activated protein kinase and nuclear factor-kappaB, but not c-Jun N-terminal kinase and activated protein-1.
Gulati AP; Yang YM; Harter D; Mukhopadhyay A; Aggarwal BB; Benzil DL; Whysner J; Albino AP; Murali R; Jhanwar-Uniyal M
Mol Carcinog; 2006 Jan; 45(1):26-37. PubMed ID: 16267831
[TBL] [Abstract][Full Text] [Related]
16. Fc epsilonRI-mediated induction of TNF-alpha gene expression in the RBL-2H3 mast cell line: regulation by a novel NF-kappaB-like nuclear binding complex.
Pelletier C; Varin-Blank N; Rivera J; Iannascoli B; Marchand F; David B; Weyer A; Blank U
J Immunol; 1998 Nov; 161(9):4768-76. PubMed ID: 9794408
[TBL] [Abstract][Full Text] [Related]
17. Induction of high-molecular-weight (HMW) tumor necrosis factor(TNF) alpha by hepatitis C virus (HCV) non-structural protein 3 (NS3) in liver cells is AP-1 and NF-kappaB-dependent activation.
Hassan M; Selimovic D; Ghozlan H; Abdel-Kader O
Cell Signal; 2007 Feb; 19(2):301-11. PubMed ID: 16916598
[TBL] [Abstract][Full Text] [Related]
18. Pyrrolidine dithiocarbamate-induced macrophage inflammatory protein-2 gene expression is NF-kappaB-independent but c-Jun-dependent in macrophage cell line RAW 264.7.
Sohn WJ; Lee KW; Lee Y; Han JH; Choe YK; Kim DS; Kwon HJ
Mol Immunol; 2005 Jun; 42(10):1165-75. PubMed ID: 15829306
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of nuclear factor-kappaB activation confers sensitivity to tumor necrosis factor-alpha by impairment of cell cycle progression in human glioma cells.
Otsuka G; Nagaya T; Saito K; Mizuno M; Yoshida J; Seo H
Cancer Res; 1999 Sep; 59(17):4446-52. PubMed ID: 10485496
[TBL] [Abstract][Full Text] [Related]
20. Dominant-negative c-Jun (TAM67) target genes: HMGA1 is required for tumor promoter-induced transformation.
Dhar A; Hu J; Reeves R; Resar LM; Colburn NH
Oncogene; 2004 May; 23(25):4466-76. PubMed ID: 15064752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]